Back
L3Harris Technologies Vs. Rhythm Pharmaceuticals Industry Stock Comparison
Buy
61
LHX
L3Harris Technologies
Last Price:
$221.20
Seasonality Move:
1.22%
Buy
65
RYTM
Rhythm Pharmaceuticals
Last Price:
$65.20
Seasonality Move:
15.42%
Buy
61
L3Harris Technologies (LHX)
is a Buy
Is L3Harris Technologies a Buy, Sell or Hold?
-
The current L3Harris Technologies [LHX] share price is $221.23. The Score for LHX is 61, which is 22% above its historic median score of 50, and infers lower risk than normal.
-
LHX is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
65
Rhythm Pharmaceuticals (RYTM)
is a Buy
Is Rhythm Pharmaceuticals a Buy, Sell or Hold?
-
The current Rhythm Pharmaceuticals [RYTM] share price is $65.22. The Score for RYTM is 65, which is 30% above its historic median score of 50, and infers lower risk than normal.
-
RYTM is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
LHX Stock Price Chart
What is L3Harris Technologies's stock price today?
-
The L3Harris Technologies share price today is $221.23Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and LHX is experiencing buying pressure, which is a positive indicator for future bullish movement.
RYTM Stock Price Chart
What is Rhythm Pharmaceuticals's stock price today?
-
The Rhythm Pharmaceuticals share price today is $65.22Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RYTM is experiencing buying pressure, which is a positive indicator for future bullish movement.
LHX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 2.26 | Buy |
Relative Strength Index (14 RSI): | 61.13 | Buy |
Chaikin Money Flow: | 711018 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (207.39 - 219.59) | Buy |
Bollinger Bands (100): | (204.11 - 221.87) | Buy |
RYTM Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 2.62 | Buy |
Relative Strength Index (14 RSI): | 66.01 | Buy |
Chaikin Money Flow: | 252910 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (52.63 - 62.47) | Buy |
Bollinger Bands (100): | (52.98 - 60.08) | Buy |
LHX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 217.01 | Buy |
20-day SMA: | 214.15 | Buy |
50-day SMA: | 210.57 | Buy |
200-day SMA: | 225.85 | Sell |
8-day EMA: | 217.69 | Buy |
20-day EMA: | 215.37 | Buy |
50-day EMA: | 213.46 | Buy |
200-day EMA: | 218.65 | Buy |
RYTM Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 62.21 | Buy |
20-day SMA: | 58.51 | Buy |
50-day SMA: | 55.56 | Buy |
200-day SMA: | 53.67 | Buy |
8-day EMA: | 62.62 | Buy |
20-day EMA: | 59.77 | Buy |
50-day EMA: | 57.26 | Buy |
200-day EMA: | 52.86 | Buy |
L3Harris Technologies Earnings Growth & LHX Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.56 per share, an increase next quarter of $0.22 per share, a decrease this year of $2.59 per share, and an increase next year of $1.61 per share.
Rhythm Pharmaceuticals Earnings Growth & RYTM Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.26 per share, an increase next quarter of $0.07 per share, an increase this year of $1.54 per share, and an increase next year of $1.14 per share.
L3Harris Technologies Technical Analysis
Apr 15 | Apr 16 | Apr 17 | Apr 21 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 28 | Apr 29 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | ||||||||||
15 | 16 | 17 | 21 | 22 | 23 | 24 | 25 | 28 | 29 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Rhythm Pharmaceuticals Technical Analysis
Apr 15 | Apr 16 | Apr 17 | Apr 21 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 28 | Apr 29 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | ||||||||||
15 | 16 | 17 | 21 | 22 | 23 | 24 | 25 | 28 | 29 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |